407 related articles for article (PubMed ID: 23660456)
1. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
Parrott AC
Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
[TBL] [Abstract][Full Text] [Related]
2. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
Parrott AC
J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
[TBL] [Abstract][Full Text] [Related]
3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
4. Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.
Parrott AC
Hum Psychopharmacol; 2013 Jul; 28(4):289-307. PubMed ID: 23881877
[TBL] [Abstract][Full Text] [Related]
5. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
6. Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.
Blagrove M; Seddon J; George S; Parrott AC; Stickgold R; Walker MP; Jones KA; Morgan MJ
J Psychopharmacol; 2011 Apr; 25(4):465-77. PubMed ID: 20615932
[TBL] [Abstract][Full Text] [Related]
7. MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.
Roberts CA; Quednow BB; Montgomery C; Parrott AC
Neurosci Biobehav Rev; 2018 Jan; 84():470-482. PubMed ID: 28801175
[TBL] [Abstract][Full Text] [Related]
8. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
[TBL] [Abstract][Full Text] [Related]
9. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
[TBL] [Abstract][Full Text] [Related]
10. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
12. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
Lyvers M
Drug Alcohol Rev; 2006 May; 25(3):269-76. PubMed ID: 16753651
[TBL] [Abstract][Full Text] [Related]
13. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
[TBL] [Abstract][Full Text] [Related]
14. Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity.
Parrott AC
Pharmacol Biochem Behav; 2002 Apr; 71(4):837-44. PubMed ID: 11888574
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
[TBL] [Abstract][Full Text] [Related]
16. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
Reay JL; Hamilton C; Kennedy DO; Scholey AB
J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
[TBL] [Abstract][Full Text] [Related]
17. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
Parrott AC
J Psychopharmacol; 2005 Jan; 19(1):71-83. PubMed ID: 15671132
[TBL] [Abstract][Full Text] [Related]
18. [The cognitive effects of ecstasy].
Pázmány P; Petschner P; Ádori C; Kirilly E; Andó DR; Balogh B; Gyöngyösi N; Bagdy G
Neuropsychopharmacol Hung; 2013 Dec; 15(4):214-22. PubMed ID: 24380962
[TBL] [Abstract][Full Text] [Related]
19. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
[TBL] [Abstract][Full Text] [Related]
20. Everyday and prospective memory deficits in ecstasy/polydrug users.
Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
